60 Degrees Pharma Announces Closing of $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Sixty Degrees Pharmaceuticals Thu, Jan 30, 2025, 2:20 PM 6 min read ...
WASHINGTON, Jan. 30, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious ...
60 Degrees Pharmaceuticals, Inc. announced the approval of an Investigational Review Board (IRB) for a Phase II clinical study aimed at evaluating the efficacy and safety of tafenoquine ...
60 Degrees Pharmaceuticals (SXTP) announced the approval of an Investigational Review Board, IRB, sanctioned Phase II clinical study. The study will evaluate the efficacy and safety of the ARAKODA ...
Enrollment expected to commence Q3 2025. WASHINGTON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on ...
Following the coldest air we have had in the area in the past three years, temperatures are projected to warm up nearly 60 degrees or more by this coming weekend and early next week. Temperatures ...
Create an account or log in to save stories. We made it. I’m 99.9 percent sure Tuesday morning’s low temperature of minus 19 degrees at Minneapolis-St. Paul International Airport will stand as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback